BLFS

BioLife Solutions, Inc.

Contracts

Total Value

Stock Metrics

10.6%

Short % Float

2.1d to cover · Low squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

T. Rowe Price Inve

Top Holder

13.3% of float

42.8M sh

Public Float

24/100

Dilution Score

Low

46 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

24/100

LOW

Inst: 1.05% · Top: T. Rowe Price Investment Management, Inc.

Biotech Analytics

Biotech / Pharma

6.79

Biotech Grade: F

Insider Buying0

Publications15

Dilution Risk24

Clinical Trials0

Short Interest50